HIV antibody therapy. Molecular model of the interaction of the HIV surface protein gp120 (purple, bottom left) as it interacts with a human white blo


HIV antibody therapy. Molecular model of the interaction of the HIV surface protein gp120 (purple, bottom left) as it interacts with a human white blood cell surface protein (CD4, green) and the anti-HIV antibody (17B, blue and red, bottom right). HIV (the human immunodeficiency virus) causes AIDS (acquired immune deficiency syndrome). The antibody neutralises the effect of gp120, helping to prevent the onset of AIDS, and is being studied for use in HIV antibody therapy. This is the HXBc2 strain of the HIV-1 form of HIV.


Size: 4827px × 3620px
Photo credit: © LAGUNA DESIGN/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: 17b, acquired, aids, antibody, artwork, background, biochemical, biochemistry, cd4, compound, cut, cut-, cut-outs, cutout, cutouts, deficiency, drug, genetic, gp120, hiv, hiv-1, hxbc2, illustration, immune, immunology, medical, medicine, model, molecular, molecule, outs, pharmaceutic, pharmaceutics, pharmacological, pharmacology, protein, proteomics, shape, structure, syndrome, therapy, treatment, viral, virology, virus, white